Enquiry/Quote
Crisaborole bulk supplier for pharma manufacturers

Crisaborole Suppliers & Bulk Manufacturers

Available Forms: Ointment

Available Strengths: 2%

Reference Brands: Eucrisa (USA/EU)

Category: Derma Drugs

Crisaborole is a non-steroidal topical phosphodiesterase 4 (PDE4) inhibitor used to treat mild to moderate atopic dermatitis (eczema). It works by reducing inflammation and easing itching and redness in affected skin areas. Crisaborole is suitable for both adults and children aged 3 months and older.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

πŸ“˜ Sourcing Guide
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing

Frequently Asked Questions

Crisaborole is used for the treatment of mild to moderate atopic dermatitis (eczema) in adults and children aged three months and older.

Crisaborole is made from a boron-based benzoxaborole compound that works as a phosphodiesterase-4 (PDE-4) inhibitor.

The trade name of Crisaborole is Eucrisa.

Crisaborole is made by Pfizer Inc.

The generic name of the product is Crisaborole.

The brand name of Crisaborole is Eucrisa.

Crisaborole is manufactured by Pfizer Inc. in the United States.

Related Products

Sofpironium Bromide

Strength:
5%, 12.45%

Form: Topical Gel

Reference Brands: ECCLOCK, Sofdra

View Details
Sarecycline

Strength:
60 mg, 100 mg, 150 mg

Form: Tablets

Reference Brands: Seysara (USA)

View Details
Afamelanotide

Strength:
16 mg

Form: Subcutaneous implant

Reference Brands: Scenesse (USA)

View Details
Glycopyrronium Tosylate

Strength:
2.4%

Form:

Reference Brands: Qbrexza (USA)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.